Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Maekura, K. Miki, S. Kitada, K. Yoshimura, Y. Tateishi, T. Hiraga, K. Fushitani (Toyonaka, Japan). Effects of oxygen inhalation during exercise in patients with combined pulmonary fibrosis and emphysema (CPFE). Eur Respir J 2010; 36: Suppl. 54, 886

Member's Comments

No comment yet.

Related content which might interest you: Short-term effects of supplemental oxygen during exercise in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019 Mechanisms of exercise limitation in patients with combined fibrosis and pulmonary emphysema Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017 Autoimmunity profile in patients with combined pulmonary fibrosis and emphysema (CPFE) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Abnormal pulmonary arterial remodelling in patients with combined pulmonary fibrosis emphysema (CPFE) and idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease Year: 2011 Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 Breathing pattern during rest and exercise in patients with cystic fibrosis (CF), pulmonary fibrosis (PF) and COPD before lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 685s Year: 2005 The impact of emphysema in pulmonary fibrosis Source: Eur Respir Rev 2013; 22: 153-157 Year: 2013 Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema Source: ERJ Open Res, 7 (3) 00316-2021; 10.1183/23120541.00316-2021 Year: 2021 Pulmonary emphysema and idiopathic pulmonary fibrosis: Is the pattern of exercise-induced oxygen desaturation same or different? Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Serum levels of surfactant proteins in patients with combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2015 – IPF pathogenesis Year: 2015 Mechanisms and consequences of exertional dyspnoea in combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases Year: 2019 Combined pulmonary fibrosis and emphysema (CPFE): How does cohabitation affect respiratory functions? Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Nitric oxide and oxygen inhalation during exercise in patients with chronic obstructive lung disease (COPD) and secondary pulmonary hypertension (PH) Source: Eur Respir J 2001; 18: Suppl. 33, 83s Year: 2001 Combined pulmonary fibrosis and emphysema syndrome (CFPE) Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Diffusing capacity for carbon monoxide (DLco) may predict appearance of pulmonary hypertension in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Effects of pulmonary rehabilitation in patients with interstitial lung disease (ILD) Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib Source: International Congress 2016 – IPF treatment II Year: 2016